<DOC>
	<DOCNO>NCT02122627</DOCNO>
	<brief_summary>Vitamin D immunomodulatory role . aim present study assess effect vitamin D supplementation exacerbation rate COPD patient vitamin D deficiency .</brief_summary>
	<brief_title>Vitamin D Supplementation Patients With COPD</brief_title>
	<detailed_description>Rationale : Although vitamin D well know function calcium homeostasis bone mineralisation , several study show immunomodulatory effect vitamin D. Vitamin D deficiency common problem patient COPD.. Objective : To assess effect vitamin D supplementation exacerbation rate patient COPD vitamin D deficiency . Study design : Randomized , multi-center , double-blind , placebo-controlled intervention study . Study population : 240 patient age 40 year old COPD vitamin D deficiency ( 25-hydroxyvitamin D concentration ( 25OHD ) &lt; 50 nmol/l ) COPD exacerbation . An exacerbation define sustained worsen respiratory symptom 48 hour require oral corticosteroid , antibiotic combination treatment initiated physician . Respiratory symptom include least one Anthonisen criterion ( increase dyspnoea , sputum volume purulence ) . Patients severe vitamin D deficiency ( 25OHD &lt; 15 nmol/l ) , know osteoporosis and/or use vitamin D supplementation &gt; 400 IU per day exclude . Intervention : Participants randomly allocate receive vitamin D3 16800 IU placebo orally week 1 year . Main study parameters/endpoints : The primary endpoint exacerbation rate .</detailed_description>
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<mesh_term>Cholecalciferol</mesh_term>
	<criteria>write informed consent age 40 year GOLD stag IIIV diagnosis COPD confirm medical doctor . minimum 10 packyears smoke vitamin D deficiency ( serum 25hydroxyvitamin D low 50 nmol/l ) ability comply study requirement pregnant lactating woman , subject intend become pregnant within study period selfreported history hypercalciemia nephrolithiasis selfreported presence sarcoidosis severe vitamin D deficiency ( serum 25hydroxyvitamin D low 15 nmol/l ) life expectation le 6 month basis concurrent disease interfere malignant disease . diagnose osteoporosis diagnose asthma diagnose chronic kidney disease stage 4 high ( estimate glomerular filtration rate â‰¤ 29 ml/min/1,73 m2 ) serious mental impairment i.e . prevent understand study protocol comply study aim ; potentially unreliable patient judge investigator unsuitable study use maintenance dose oral corticosteroid use multivitamin supplement vitamin D supplement contain 400 IU per day current participation clinical rehabilitation programme</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>Vitamin D , COPD , immunomodulation , physical function , pulmonary function</keyword>
</DOC>